Saverio Minucci
Via Mangiagalli 25
Milan, 20133, Italy
Milan, 20133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 181 publications
First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models.
Journal: Journal of medicinal chemistry
Published: May 26, 2026
Spatiotemporal atlas of pro-inflammatory NF-κB and anti-inflammatory STAT6 signaling using reporter mice during mRNA vaccination.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 04, 2026
Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 20, 2026
Neonatal genetic screening of Glucose-6-phosphate dehydrogenase deficiency through next-generation sequencing.
Journal: British journal of haematology
Published: November 16, 2025
Mapping Genomic Heterogeneity in Pediatric and Adolescent-Young Adult Sarcomas: Insights from the Italian SAR-GEN2016 and SAR-GEN_ITA Prospective Multicenter Trials.
Journal: Cancer research communications
Published: November 06, 2025
A Genomic Sequencing Approach to Newborn Mass Screening and Its Opportunities.
Journal: JAMA network open
Published: October 17, 2025
Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 01, 2025
Editor's Note: c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 12, 2025
Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: April 01, 2025
Structural Optimization and MD Simulation Study of Benzimidazole Derivatives as Potent Mutant FLT3 Kinase Inhibitors Targeting AML.
Journal: Archiv der Pharmazie
Published: January 20, 2025
A histone-centric multi-omics study shows that increased H3K4 methylation sustains triple-negative breast cancer phenotypes.
Journal: Nature communications
Published: December 03, 2024
Last Updated: 09/26/2026